Funding for this research was provided by:
National Center for Complementary and Integrative Health (AT007830)
Article History
Received: 24 February 2020
Revised: 18 June 2020
Accepted: 2 July 2020
First Online: 21 July 2020
Compliance with ethical standards
:
: SSD holds a patent for the use of engineered bacteria for the treatment of obesity. NSD and LSD have no conflicts of interests.
: This review article does not include any new animal or human studies performed by any of the authors. Previously published animal studies by the authors followed applicable national and institution guidelines for the care and use of animals.